glp 1 oral medication Novo Nordisk's GLP-1 drug didn't work on Alzheimer's as hoped, but don't call it a failure Oral GLP-1s rapidly expanding user
Description
These changes often lead to increased food intake and gradual weight regain
Wegovy carries a higher list price ($1,349.02) reflecting its obesity treatment indication versus Ozempic ($997.58) for diabetes
Nausea, vomiting, diarrhea, and constipation were the most common gastrointestinal adverse effects
Meline 2024)
However, doctors soon discovered that patients also experienced significant weight loss
In addition, T2D patients are prone to losing SKM more rapidly than non-diabetic people, thus becoming more susceptible to insulin resistance than the general population
